Six Spanish-language publications from the U.S. government help patients compare treatments for common illnesses such as heart disease, officials say. The Agency for Healthcare Research and Quality publications summarize the benefits and risks of the medications ACE Inhibitors, or angiotensin-converting enzyme, and ARBs or angiotensin II receptor blockers. The medications help reduce blood pressure in patients who often take other heart-related medications such as aspirin, blood thinners or cholesterol-lowering drugs, officials of the Health and Human Resources' Agency for Healthcare Research and Quality say. "This new Spanish-language guide on heart medications is part of AHRQ's ongoing effort to give Hispanics the knowledge they need to take a greater role in their healthcare," AHRQ Director Dr. Carolyn M. Clancy says in a statement. "All patients should have access to the best information available so they can work with their doctor to identify the best treatment for them." The AHRQ offers 23 publications in Spanish that compare treatments for heart and vascular system conditions, diabetes, cancer, bone and joint-related conditions, pregnancy, mental health and digestive system ailments, Clancy says.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkillerMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor